Change impact underestimated during deviation investigation – inspection questions regulators ask


Published on 25/04/2026

Understanding the Impact of Change During Deviation Investigations: Essential Inspection Questions

In the tightly regulated pharmaceutical industry, the integrity of manufacturing processes and quality control mechanisms is paramount. When a deviation occurs, it is crucial to understand how changes—especially those involving raw materials—may impact product quality and safety. This playbook provides a thorough approach to effectively evaluate, manage, and document the impacts of changes during deviation investigations, ensuring compliance and readiness for inspections by FDA, EMA, and MHRA.

By the end of this article, you will know how to identify the symptoms of deviations, conduct a rigorous investigation, implement corrective and preventive actions (CAPA), and prepare your documentation for inspection readiness, particularly regarding change control related to raw materials.

Symptoms/Signals on the Floor or in the Lab

A deviation can manifest symptoms that may indicate underlying issues. It’s critical for stakeholders in Production, QC, and QA to be vigilant. Some common symptoms to watch for include:

  • Out-of-Specification Results: Variability in assay results or purity of the
product can signal issues with raw material quality.
  • Increased Scrap Rates: A higher than normal rate of rejects or non-conforming material may suggest quality issues linked to changes in processes or materials.
  • Process Variability: Fluctuations in critical process parameters that deviate from established norms can indicate a problem.
  • Inconsistencies in Batch Records: Deviations can lead to missing or contradictory information in batch documentation, impacting traceability.
  • These symptoms often serve as the initial indicators that a deviation needs immediate attention. Gathering this information should be the first step to understanding the technical impact of the deviation.

    Likely Causes

    When deviations occur, understanding the potential causes is essential for effective troubleshooting. The “5Ms” framework—Materials, Method, Machine, Man, Measurement, and Environment—serves as a resource for identifying these causes:

    Category Potential Causes Example Indicators
    Materials Quality control failures, Unknown raw material changes Out-of-specification assay results
    Method Changes in SOPs, Unapproved alterations to processes Inconsistent processing times
    Machine Aging equipment, Calibration issues Increased downtime, Fluctuating process parameters
    Man Training deficiencies, Workforce changes Increased error rates, Non-compliance with SOPs
    Measurement Faulty instruments, Incorrect methods of verification Frequent calibration fails, Inaccurate readings
    Environment Uncontrolled conditions, Changes in utilities or facilities Detected contamination, Out-of-spec environmental conditions

    Identifying the root of deviations through these categories can assist in addressing the issues effectively.

    Immediate Containment Actions (First 60 Minutes)

    Once a deviation is detected, swift action is crucial. Here are steps for immediate containment relevant to both Production and QA teams:

    • Notify Management: Immediately escalate the deviation to management and relevant department heads to initiate an emergency response.
    • Isolate Affected Material: Quarantine any material or equipment linked to the deviation to prevent further impact on the production process.
    • Document Everything: Start documenting the deviation details, including time, personnel involved, and observed symptoms.
    • Assess Impacts: Conduct a quick risk assessment to determine if products already released could be affected.
    • Modify Processes: Adjust ongoing processes, as needed, to avoid exacerbating the issue while a full investigation is conducted.

    Investigation Workflow

    Following immediate containment, an investigation workflow should be initiated. This process should be followed by QA and Production under strict adherence to established protocols:

    1. Data Collection: Gather all relevant data, including batch records, testing results, and observations from affected personnel.
    2. Interviews: Conduct interviews with all staff involved to gather qualitative information about the circumstances surrounding the deviation.
    3. Initial Records Review: Review batch production records, equipment logs, and relevant SOPs to identify discrepancies.
    4. Trend Analysis: Use software tools for statistical process control (SPC) to look for trends associated with the deviation.
    5. Documentation: Ensure all findings and evaluations are documented comprehensively for regulatory compliance and future audits.

    Root Cause Tools

    Applying root cause analysis (RCA) techniques is essential for identifying underlying issues. Here are three tools that can be utilized and when:

    • 5-Why Analysis: Useful for straightforward problems with direct causes. This iterative questioning technique helps peel the layers of symptoms to get to the root cause.
    • Fishbone Diagram: Ideal for more complex issues involving multiple categories of causes. This visual tool allows teams to brainstorm potential causes systematically.
    • Fault Tree Analysis: Best for complex engineering problems, this deductive analysis method helps identify root causes through logical relationships.

    CAPA Strategy

    A well-structured Corrective and Preventive Actions (CAPA) strategy is essential in response to identified root causes. Here’s a typical framework you can follow:

    1. Correction: Address the immediate issue by preventing further defective batches. For example, consider temporarily halting production or issuing a recall as necessary.
    2. Corrective Action: Based on the root cause analysis, develop long-term solutions that adjust SOPs, retrain personnel, or upgrade equipment.
    3. Preventive Action: Establish monitoring processes to ensure the same issues do not recur, including revising change control procedures specifically for raw materials.

    Control Strategy & Monitoring

    Implement an ongoing control strategy to minimize risks associated with raw material changes. Insights from SPC and monitoring metrics play a significant role:

    • Statistical Process Control (SPC): Utilize SPC methods to analyze process data and monitor for trends that may suggest deviations.
    • Alarm Systems: Establish alarm systems to alert operators of process deviations in real time, particularly those affecting critical quality attributes.
    • Sampling Plans: Create robust sampling plans that ensure regular testing of raw materials and intermediates for conformity with specifications.
    • Trend Monitoring: Regularly review historical data to identify patterns or recurrent issues that may require root cause investigations.

    Validation / Re-qualification / Change Control Impact

    Investigating a deviation often necessitates re-evaluating validation protocols, especially when changes impact raw materials or processes:

    • Validation Impact Assessment: After a deviation investigation, determine if a revalidation of the affected process is warranted based on the findings.
    • Change Control Procedure: Follow formal change control protocols for any adjustments to raw material suppliers, specifications, or processing methods affected by the deviation.
    • Re-qualification Needs: Address whether re-qualification of equipment or facilities is required based on the outcomes of the deviation.

    Inspection Readiness: What Evidence to Show

    To prepare for inspections by regulators like the FDA, EMA, and MHRA, comprehensive and detailed documentation is key:

    Related Reads

    • Records of Deviation: Ensure clear, chronological records of the deviation itself, including all associated documentation.
    • CAPA Documentation: Thorough documentation of corrective actions taken, root cause analysis conducted, and preventive measures implemented.
    • Batch Records: Include all relevant batch production records and testing results to demonstrate adherence to protocols and specifications.
    • Re-evaluation Records: Document all re-evaluations of changes resulting from the deviation to exhibit compliance with change controls.

    FAQs

    What should be the first step upon discovering a deviation?

    The immediate step is to notify management and begin documenting the deviation while initiating containment actions.

    How can I assess the impact of a raw material change?

    Conduct a risk assessment considering the batch records, impact on product quality, and whether the change aligns with existing specifications.

    Which RCA tool should I use?

    Choose based on complexity: use 5-Why for straightforward issues, Fishbone for broader analysis, and Fault Tree for complex, systematic issues.

    How often should we review our control strategy?

    A review should occur regularly during quality management meetings and after significant deviations or changes to material suppliers.

    What documentation is essential for inspection readiness?

    Critical documents include deviation reports, CAPA logs, batch records, and re-evaluation documents regarding changes.

    Is re-validation needed after every deviation?

    Not necessarily; it depends on the severity of the deviation and its impact on validated processes and products.

    When to escalate a deviation investigation to upper management?

    Escalation is warranted if a deviation has potential or confirmed affects on product safety, efficacy, or quality.

    What constitutes a significant deviation?

    A significant deviation typically involves any impact on product quality, compliance, or patient safety that could trigger non-compliance concerns.

    Are raw material changes always documented?

    Yes, any approved change in raw materials must go through a formal change control process, accurately documented for traceability.

    What are the risks linked to raw material changes?

    Risks include contamination, inconsistent product quality, or non-compliance with regulatory standards, potentially leading to recalls or fines.

    How can I ensure changes do not lead to nitrosamine formation?

    Implement rigorous assessments and monitoring of raw materials known to carry nitrosamine risk to maintain quality and safety.

    What regulatory frameworks guide change control?

    Regulatory frameworks include FDA Guidance Documents, EMA Quality Guidelines, and MHRA guidance on change control in pharmaceuticals.

    Pharma Tip:  Supplier change not evaluated during post-approval change review – preventing batch rejection and recalls